Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 2014. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The filing details a specific transaction on January 9, 2014:
- Connected Person: Mr P C Thomson and Mrs K Thomson.
- Transaction Type: Acquisition of 12 Ordinary Shares.
- Price: 1622.61 pence per Ordinary Share.
- Mechanism: Reinvestment of dividends paid on shares held in the GlaxoSmithKline ShareReward Plan.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the share acquisition in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Key Facts for Investor Verification
- Verify the total shareholding of Mr P C Thomson and Mrs K Thomson following this acquisition.
- Confirm the terms of the GlaxoSmithKline ShareReward Plan regarding dividend reinvestment.
- Note that this filing does not contain financial performance data for the period.